{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:12:39Z","timestamp":1794003159720,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/s10038-017-0389-4","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T04:08:21Z","timestamp":1515557301000},"page":"271-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Nationwide survey on cerebrotendinous xanthomatosis in Japan"],"prefix":"10.1038","volume":"63","author":[{"given":"Yoshiki","family":"Sekijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneaki","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Koinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"389_CR1","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","volume":"266","author":"JJ Cali","year":"1991","unstructured":"Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266:7779\u201383.","journal-title":"J Biol Chem"},{"key":"389_CR2","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1016\/S0021-9258(20)89517-9","volume":"266","author":"JJ Cali","year":"1991","unstructured":"Cali JJ, Russell DW. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem. 1991;266:7774\u20138.","journal-title":"J Biol Chem."},{"key":"389_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/brain\/123.5.908","volume":"123","author":"A Verrips","year":"2000","unstructured":"Verrips A, Hoefsloot LH, Steenbergen GC, Theelen JP, Wevers RA, Gabreels FJ, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain. 2000;123:908\u201319.","journal-title":"Brain."},{"key":"389_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","volume":"27","author":"GN Gallus","year":"2006","unstructured":"Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci. 2006;27:143\u20139.","journal-title":"Neurol Sci."},{"key":"389_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1468-1331.2010.03002.x","volume":"17","author":"GN Gallus","year":"2010","unstructured":"Gallus GN, Dotti MT, Mignarri A, Rufa A, Da Pozzo P, Cardaioli E, et al. Four novel CYP27A1 mutations in seven Italian patients with CTX. Eur J Neurol. 2010;17:1259\u201362.","journal-title":"Eur J Neurol."},{"key":"389_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2169\/internalmedicine.49.3277","volume":"49","author":"T Nozue","year":"2010","unstructured":"Nozue T, Higashikata T, Inazu A, Kawashiri MA, Nohara A, Kobayashi J, et al. Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis. Intern Med. 2010;49:1127\u201331.","journal-title":"Intern Med."},{"key":"389_CR7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-2275(20)37212-6","volume":"38","author":"W Chen","year":"1997","unstructured":"Chen W, Kubota S, Kim KS, Cheng J, Kuriyama M, Eggertsen G, et al. Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families. J Lipid Res. 1997;38:870\u20139.","journal-title":"J Lipid Res"},{"key":"389_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejmg.2011.08.003","volume":"55","author":"S Suh","year":"2012","unstructured":"Suh S, Kim HK, Park HD, Ki CS, Kim MY, Jin SM, et al. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene. Eur J Med Genet. 2012;55:71\u20134.","journal-title":"Eur J Med Genet."},{"key":"389_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)31675-8","volume":"42","author":"MH Lee","year":"2001","unstructured":"Lee MH, Hazard S, Carpten JD, Yi S, Cohen J, Gerhardt GT, et al. Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. J Lipid Res. 2001;42:159\u201369.","journal-title":"J Lipid Res."},{"key":"389_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1023\/A:1021211520034","volume":"25","author":"PT Clayton","year":"2002","unstructured":"Clayton PT, Verrips A, Sistermans E, Mann A, Mieli-Vergani G, Wevers R. Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2002;25:501\u201313.","journal-title":"J Inherit Metab Dis."},{"key":"389_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","volume":"311","author":"VM Berginer","year":"1984","unstructured":"Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311:1649\u201352.","journal-title":"N Engl J Med."},{"key":"389_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","volume":"18","author":"B Pilo-De-La-Fuente","year":"2011","unstructured":"Pilo-De-La-Fuente B, Jimenez-Escrig A, Lorenzo JR, Pardo J, Arias M, Ares-Luque A, et al. Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol. 2011;18:1203\u201311.","journal-title":"Eur J Neurol."},{"key":"389_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","volume":"37","author":"A Mignarri","year":"2014","unstructured":"Mignarri A, Gallus GN, Dotti MT, Federico A. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014;37:421\u20139.","journal-title":"J Inherit Metab Dis."},{"key":"389_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"389_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymgme.2015.10.010","volume":"116","author":"V Appadurai","year":"2015","unstructured":"Appadurai V, Debarber A, Chiang PW, Patel SB, Steiner RD, Tyler C, et al. Apparent underdiagnosis of cerebrotendinous xanthomatosis revealed by analysis of ~60,000 human exomes. Mol Genet Metab. 2015;116:298\u2013304.","journal-title":"Mol Genet Metab."},{"key":"389_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s004310050818","volume":"157","author":"AF Heijst Van","year":"1998","unstructured":"Van Heijst AF, Verrips A, Wevers RA, Cruysberg JR, Renier WO, Tolboom JJ. Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr. 1998;157:313\u20136.","journal-title":"Eur J Pediatr."},{"key":"389_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-510X(01)00563-9","volume":"190","author":"M Mondelli","year":"2001","unstructured":"Mondelli M, Sicurelli F, Scarpini C, Dotti MT, Federico A. Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study. J Neurol Sci. 2001;190:29\u201333.","journal-title":"J Neurol Sci"},{"key":"389_CR18","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.2169\/internalmedicine.53.2996","volume":"53","author":"T Yoshinaga","year":"2014","unstructured":"Yoshinaga T, Sekijima Y, Koyama S, Maruyama K, Yoshida T, Kato T, et al. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene. Intern Med. 2014;53:2725\u20139.","journal-title":"Intern Med."},{"key":"389_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1212\/WNL.41.3.434","volume":"41","author":"J Peynet","year":"1991","unstructured":"Peynet J, Laurent A, De Liege P, Lecoz P, Gambert P, Legrand A, et al. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. Neurology. 1991;41:434\u20136.","journal-title":"Neurology."},{"key":"389_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00415-008-0729-6","volume":"255","author":"B Pilo De La Fuente","year":"2008","unstructured":"Pilo De La Fuente B, Ruiz I, Lopez De Munain A, Jimenez-Escrig A. Cerebrotendinous xanthomatosis: neuropathological findings. J Neurol. 2008;255:839\u201342.","journal-title":"J Neurol."},{"issue":"Suppl 2","key":"389_CR21","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1007\/s10545-008-0815-z","volume":"31","author":"G Pierre","year":"2008","unstructured":"Pierre G, Setchell K, Blyth J, Preece MA, Chakrapani A, Mckiernan P. Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy. J Inherit Metab Dis. 2008;31(Suppl 2):S241\u20135.","journal-title":"J Inherit Metab Dis."},{"key":"389_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/brain\/122.8.1589","volume":"122","author":"A Verrips","year":"1999","unstructured":"Verrips A, Nijeholt GJ, Barkhof F, Van Engelen BG, Wesseling P, Luyten JA, et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain. 1999;122:1589\u201395.","journal-title":"Brain."},{"key":"389_CR23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1179\/1079026815Z.000000000409","volume":"39","author":"R Abe","year":"2016","unstructured":"Abe R, Sekijima Y, Kinoshita T, Yoshinaga T, Koyama S, Kato T, et al. Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion. J Spinal Cord Med. 2016;39:726\u20139.","journal-title":"J Spinal Cord Med."},{"key":"389_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0542-2","volume":"16","author":"M Yanagihashi","year":"2016","unstructured":"Yanagihashi M, Kano O, Terashima T, Kawase Y, Hanashiro S, Sawada M, et al. Late-onset spinal form xanthomatosis without brain lesion: a case report. BMC Neurol. 2016;16:21.","journal-title":"BMC Neurol."},{"key":"389_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/practneurol-2015-001117","volume":"15","author":"Z Nicholls","year":"2015","unstructured":"Nicholls Z, Hobson E, Martindale J, Shaw PJ. Diagnosis of spinal xanthomatosis by next-generation sequencing: identifying a rare, treatable mimic of hereditary spastic paraparesis. Pract Neurol. 2015;15:280\u20133.","journal-title":"Pract Neurol."},{"key":"389_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10545-014-9745-0","volume":"38","author":"JA Saute","year":"2015","unstructured":"Saute JA, Giugliani R, Merkens LS, Chiang JP, Debarber AE, De Souza CF. Look carefully to the heels! A potentially treatable cause of spastic paraplegia. J Inherit Metab Dis. 2015;38:363\u20134.","journal-title":"J Inherit Metab Dis."},{"key":"389_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1600-0404.1975.tb01380.x","volume":"51","author":"A Schreiner","year":"1975","unstructured":"Schreiner A, Hopen G, Skrede S. Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family. Acta Neurol Scand. 1975;51:405\u201316.","journal-title":"Acta Neurol Scand"},{"key":"389_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00000441-198205000-00005","volume":"283","author":"M Swartz","year":"1982","unstructured":"Swartz M, Burman KD, Salen G. Cerebrotendinous xanthomatosis: a cause of cataracts and tendon xanthoma. Am J Med Sci. 1982;283:147\u201352.","journal-title":"Am J Med Sci."},{"key":"389_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0022-510X(91)90073-G","volume":"102","author":"M Kuriyama","year":"1991","unstructured":"Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci. 1991;102:225\u201332.","journal-title":"J Neurol Sci."},{"key":"389_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0022-510X(92)90143-9","volume":"112","author":"D Restuccia","year":"1992","unstructured":"Restuccia D, Di Lazzaro V, Servidei S, Colosimo C, Tonali P. Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study. J Neurol Sci. 1992;112:139\u201346.","journal-title":"J Neurol Sci."},{"key":"389_CR31","first-page":"1721","volume":"15","author":"MT Dotti","year":"1994","unstructured":"Dotti MT, Federico A, Signorini E, Caputo N, Venturi C, Filosomi G, et al. Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. Am J Neuroradiol. 1994;15:1721\u20136.","journal-title":"Am J Neuroradiol."},{"key":"389_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0009-8981(85)90182-2","volume":"152","author":"BJ Koopman","year":"1985","unstructured":"Koopman BJ, Wolthers BG, Van Der Molen JC, Waterreus RJ. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Clin Chim Acta. 1985;152:115\u201322.","journal-title":"Clin Chim Acta."},{"key":"389_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0022-510X(94)90237-2","volume":"125","author":"M Kuriyama","year":"1994","unstructured":"Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use. J Neurol Sci. 1994;125:22\u20138.","journal-title":"J Neurol Sci."},{"key":"389_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jns.2003.07.005","volume":"216","author":"S Ito","year":"2003","unstructured":"Ito S, Kuwabara S, Sakakibara R, Oki T, Arai H, Oda S, et al. Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis. J Neurol Sci. 2003;216:179\u201382.","journal-title":"J Neurol Sci."},{"key":"389_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0022-510X(93)90303-G","volume":"114","author":"Y Mimura","year":"1993","unstructured":"Mimura Y, Kuriyama M, Tokimura Y, Fujiyama J, Osame M, Takesako K, et al. Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis. J Neurol Sci. 1993;114:227\u201330.","journal-title":"J Neurol Sci."},{"key":"389_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0022-510X(94)90357-3","volume":"121","author":"VM Berginer","year":"1994","unstructured":"Berginer VM, Salen G. LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosis. J Neurol Sci. 1994;121:229\u201332.","journal-title":"J Neurol Sci."},{"key":"389_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10072-004-0320-6","volume":"25","author":"MT Dotti","year":"2004","unstructured":"Dotti MT, Lutjohann D, Von Bergmann K, Federico A. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis. Neurol Sci. 2004;25:185\u201391.","journal-title":"Neurol Sci."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-017-0389-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-017-0389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-017-0389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:05:43Z","timestamp":1684616743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-017-0389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1038\/s10038-017-0389-4","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"1 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}